Digital Technologies for Assessing Patient Functioning in Multiple Sclerosis Clinical Trials Social Materials
December 1, 2020
Join ERT and Cogstate on Tuesday, December 1 for a webinar that will present advances in validated tools and technologies to collect digital endpoints relevant to MS and other Neuromuscular diseases. These solutions have the ability to improve signal detection and gather relevant data needed to measure treatment response. The speakers will review examples of how these technologies have provided high quality outcome measures via sensitive, reliable, and objective assessments which fully characterize motor and cognitive impairment.
Watch this webinar to gain a greater understanding of:
- The use of digital tools in MS clinical research
- Practical approaches to the selection of fit-for-purpose assessments and development of endpoint strategies for MS clinical trials
- Case studies in the application of cognitive and motor assessments
DR. FAY HORAK
Chief Scientist, Wearables & Digital Biomarkers
Dr. Fay Horak is Chief Scientific Officer at APDM Wearable Technology, an ERT company. She is also Professor of Neurology, Behavioral Neuroscience, and Bioengineering and Director of the Balance Disorders laboratory at Oregon Health and Science University. Dr. Horak is a physical therapist and neuroscientist who is internationally known for her research on the physiology of balance disorders and their rehabilitation.
DR. CHRIS EDGAR
Chief Science Officer
Dr. Chris Edgar is an experienced leader in cognitive assessment and clinical endpoint strategy who provides expert guidance to Cogstate’s pharmaceutical customers throughout all stages of trial conduct, from study design and test selection through final analysis. He holds a PhD in psychopharmacology from Northumbria University and has 20 years of pharmaceutical industry experience.